PL2408299T3 - Kompozycje monoglicerydu kwasu tłuszczowego - Google Patents

Kompozycje monoglicerydu kwasu tłuszczowego Download PDF

Info

Publication number
PL2408299T3
PL2408299T3 PL10754148T PL10754148T PL2408299T3 PL 2408299 T3 PL2408299 T3 PL 2408299T3 PL 10754148 T PL10754148 T PL 10754148T PL 10754148 T PL10754148 T PL 10754148T PL 2408299 T3 PL2408299 T3 PL 2408299T3
Authority
PL
Poland
Prior art keywords
fatty acid
acid monoglyceride
monoglyceride compositions
compositions
fatty
Prior art date
Application number
PL10754148T
Other languages
English (en)
Polish (pl)
Inventor
Jon Lenn
Barry Hunt
Edward Hsia
Hans Hofland
Original Assignee
Stiefel Laboratories
Stiefel Res Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42740006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2408299(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Laboratories, Stiefel Res Australia Pty Ltd filed Critical Stiefel Laboratories
Publication of PL2408299T3 publication Critical patent/PL2408299T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10754148T 2009-03-20 2010-03-19 Kompozycje monoglicerydu kwasu tłuszczowego PL2408299T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20263509P 2009-03-20 2009-03-20
US21331309P 2009-05-28 2009-05-28
EP10754148.4A EP2408299B1 (en) 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions
PCT/US2010/027905 WO2010108060A1 (en) 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions

Publications (1)

Publication Number Publication Date
PL2408299T3 true PL2408299T3 (pl) 2014-03-31

Family

ID=42740006

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10754148T PL2408299T3 (pl) 2009-03-20 2010-03-19 Kompozycje monoglicerydu kwasu tłuszczowego

Country Status (15)

Country Link
US (2) US20110305646A1 (enExample)
EP (1) EP2408299B1 (enExample)
JP (1) JP5992324B2 (enExample)
KR (1) KR101506369B1 (enExample)
CN (1) CN102368904B (enExample)
AU (1) AU2010226476B2 (enExample)
BR (1) BRPI1014529A2 (enExample)
CA (1) CA2756047C (enExample)
CL (1) CL2011002302A1 (enExample)
EA (1) EA022569B1 (enExample)
ES (1) ES2437395T3 (enExample)
IL (1) IL214887A (enExample)
MX (1) MX2011009781A (enExample)
PL (1) PL2408299T3 (enExample)
WO (1) WO2010108060A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2434892B1 (en) * 2009-05-29 2015-08-19 Palau Pharma, S.A. Azole antifungal compositions
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US20160166491A1 (en) * 2014-03-26 2016-06-16 Mandom Corporation Deodorant composition and deodorant agent
CN104672506A (zh) * 2015-02-02 2015-06-03 安徽玉堂雨具有限公司 一种抗菌防霉生物降解塑料及其制备方法
EP3468544A2 (en) * 2016-06-13 2019-04-17 Vyome Therapeutics Limited Synergistic antifungal compositions and methods thereof
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
AU2020408342B2 (en) * 2019-12-20 2024-02-22 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Topical pharmaceutical compositions for treating onychomycosis
KR102442047B1 (ko) * 2020-09-10 2022-09-08 서울대학교산학협력단 설페이트와 아민기를 함유하는 지방산 글리세리드 화합물, 이의 생산 방법, 및 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
FI912955A7 (fi) * 1990-06-25 1991-12-26 Res Foundation For Mental Hygiene Antimikrobiset rasvahappokoostumukset
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
RU2122402C1 (ru) * 1995-07-18 1998-11-27 Научно-производственная фирма "Фаркос" Товарищество с ограниченной ответственностью Средство для лечения и профилактики грибковых заболеваний кожи на основе гризеофульвина
DE19540465A1 (de) 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
PL357111A1 (en) * 2000-02-16 2004-07-12 Bentley Pharmaceuticals, Inc. Pharmaceutical composition
JP2004043336A (ja) * 2002-07-10 2004-02-12 Naris Cosmetics Co Ltd 抗菌剤及びそれを配合してなる化粧料
KR20050030205A (ko) * 2002-07-22 2005-03-29 시바 스폐셜티 케미칼스 홀딩 인코포레이티드 공중합체 및 개인 케어 조성물에의 용도
US20050165104A1 (en) * 2002-07-24 2005-07-28 Holwerda James G. Biocidal agents and veterinary methods
EP1633818A2 (en) * 2003-04-18 2006-03-15 MERCK PATENT GmbH Antimicrobial pigments
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
RU2337689C1 (ru) * 2007-04-18 2008-11-10 Общество с ограниченной ответственностью "Фармацевтические технологии" Средство для лечения поверхностных микозов
AU2009240389A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections

Also Published As

Publication number Publication date
ES2437395T3 (es) 2014-01-10
WO2010108060A1 (en) 2010-09-23
CA2756047C (en) 2016-04-26
EA022569B1 (ru) 2016-01-29
CN102368904A (zh) 2012-03-07
BRPI1014529A2 (pt) 2015-08-25
AU2010226476B2 (en) 2013-02-07
WO2010108060A8 (en) 2011-12-29
CL2011002302A1 (es) 2012-06-22
EA201171150A1 (ru) 2012-03-30
IL214887A0 (en) 2011-11-30
EP2408299A4 (en) 2012-08-15
IL214887A (en) 2015-09-24
CN102368904B (zh) 2014-03-26
JP5992324B2 (ja) 2016-09-14
EP2408299B1 (en) 2013-10-23
US20110305646A1 (en) 2011-12-15
CA2756047A1 (en) 2010-09-23
KR20120014553A (ko) 2012-02-17
EP2408299A1 (en) 2012-01-25
US20180360791A1 (en) 2018-12-20
AU2010226476A1 (en) 2011-09-22
JP2012521351A (ja) 2012-09-13
KR101506369B1 (ko) 2015-03-30
MX2011009781A (es) 2011-10-17

Similar Documents

Publication Publication Date Title
IL214887A0 (en) Fatty acid monoglyceride compositions
IL251846A0 (en) lipid preparations
PL2501375T3 (pl) Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe
EP2433630A4 (en) SELF-EMULSIFIABLE COMPOSITION OF FATTY ACID 3
EP2459189A4 (en) FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS
ZA201109176B (en) Homeglobin compositions
IL217949A0 (en) Pesticdal compositions
EP2498602A4 (en) STABILIZED FORMULATIONS FROM FATTY ACIDS
ZA201200311B (en) Skincare compositions
GB0906515D0 (en) Fungical compositions
PT2442645E (pt) Ésteres de colina
ZA201108850B (en) Solid compositions comprising 5-aminolevulinic acid
ZA201109312B (en) Compositions
EP2637660A4 (en) GRAS SYNTHASE ACID INHIBITORS
ZA201201063B (en) Novel fatty acid desaturases and elongases and uses thereof
GB201017722D0 (en) Edible Composition
EP2503890A4 (en) AZABENZIMIDAZOLE AS A FATTY ACID SYNTHESIS HEMMER
EP2493310A4 (en) BENZIMIDAZOLES AS INHIBITORS OF ACID GRAS SYNTHASE
ZA201203039B (en) Sunscreen composition with fatty acid alkanolamides
IL219958A0 (en) Omega-3 fatty acid enriched meat compositions
EP2542232A4 (en) FATTY ACID INHIBITORS
GB0905165D0 (en) Compositions
GB0904300D0 (en) Essential fatty acid compounds
ZA201301490B (en) Fragranced spoap compositions
PL2550345T3 (pl) Podpałka na bazie estru kwasu tłuszczowego